Skip to content
Back to search results

Chronic Respiratory Disease Questionnaire

Introduced by
Gordon H. Guyatt, McMaster University
Year
1987
Type
Self-report or interviewer-administered questionnaire
Family
respiratory-qol
Font size

What does it do?

The CRQ is a 20-item, four-domain questionnaire developed by Guyatt and colleagues at McMaster University in 1987 to measure health-related quality of life specifically in patients with chronic respiratory disease, particularly chronic obstructive pulmonary disease and cystic fibrosis.

Uniquely, the CRQ can be administered by interview or self-report, and its four domains (dyspnea, fatigue, emotional function, mastery) directly address the multidimensional burden of chronic respiratory disease. The CRQ has demonstrated exceptional responsiveness to pulmonary rehabilitation and other interventions, making it a preferred outcome measure in respiratory research and clinical practice.

The intuition behind the method

The CRQ recognizes that chronic respiratory disease affects far more than breathing: it saps energy (fatigue), triggers emotional distress (anxiety, depression), and undermines confidence in managing daily life (loss of mastery). Guyatt's team designed the CRQ to capture these four interconnected dimensions through personalized questioning. Patients are asked about their own specific activities (e.g., 'climbing stairs', 'playing with grandchildren') rather than generic exertions, making each patient's CRQ tailored and emotionally resonant. This person-centered approach ensures high responsiveness: when a patient begins pulmonary rehabilitation and gains strength, the CRQ detects improvement across all four domains, affirming the holistic benefit of intervention.

History

Guyatt and colleagues at McMaster University developed the CRQ in 1987, published in Thorax as a response to the limited responsiveness of generic health measures in respiratory disease trials. The CRQ's personalized approach and interview format were innovative; the study demonstrated that the CRQ was far more responsive to pulmonary rehabilitation effects than the SF-36. The CRQ has since been widely adopted in respiratory research and clinical practice, with translations in >15 languages. Later variants include the CRQ-SAS (Self-Administered Standardized), which standardizes dyspnea items across patients, improving comparability at the expense of personalization.

When to use it

The CRQ is indicated for patients with chronic respiratory disease (COPD, cystic fibrosis, ILD, asthma) where multidimensional quality-of-life assessment is desired. It is particularly valuable in pulmonary rehabilitation programs (superior responsiveness to rehabilitation compared to generic tools), clinical trials evaluating comprehensive interventions, and longitudinal disease monitoring in respiratory specialty clinics. The CRQ's interview format is preferred when administering to patients with cognitive impairment or low literacy. It is less suitable for acute settings or when time constraints demand extreme brevity.

Limitations and considerations

  • Length: 20 items plus personalized dyspnea selection requires 20–30 minutes interview time, limiting feasibility in busy clinics
  • Interview training required: Optimal administration by trained clinician; self-report may reduce responsiveness and comparability
  • Limited normative data: Fewer population studies compared to SGRQ; reference values less established in diverse populations
  • Dyspnea personalization complexity: Selecting appropriate dyspnea activities requires clinical judgment; inconsistent selection across visits may confound longitudinal comparison

Source conditions do not replace independent scientific review or validation by an analysis engine.

Strengths

  • Exceptional responsiveness: CRQ is highly sensitive to changes from rehabilitation, medication adjustments, and disease progression; demonstrates responsiveness superior to SF-36 in COPD populations
  • Multidimensional: Four domains (dyspnea, fatigue, emotion, mastery) capture the full spectrum of respiratory disease burden, not just symptoms
  • Personalized content: Dyspnea items tailored to patient's own activities; increases relevance and emotional resonance compared to generic activity lists
  • Flexible administration: Interview or self-report formats accommodate diverse patient populations (literacy, cognitive status, language barriers)

Applications

  • Pulmonary rehabilitation outcome measurement: Primary or secondary endpoint in rehabilitation programs; CRQ demonstrates superior responsiveness to 6-minute walk distance or FEV₁ alone in detecting holistic benefit
  • COPD medication trials: Evaluation of new medications or inhalers using CRQ to quantify impacts on exertional dyspnea, fatigue, emotional well-being, and treatment confidence
  • Longitudinal disease monitoring: Repeated CRQ assessments in specialty clinics to track disease progression and guide treatment escalation, particularly for fatigue or emotional components
  • Cystic fibrosis and ILD outcomes: Disease-specific outcome in CF and ILD trials; CRQ captures the systemic burden of these chronic conditions better than symptom-focused measures

How it works

How it works

1

The CRQ can be administered by trained clinician interview (preferred for maximizing responsiveness) or by self-completion. The four domains are: (1) Dyspnea (5 items, selected by patient from list of common activities—e.g., stairs, yard work, walking—then rated on exertional severity); (2) Fatigue (4 items rating energy levels and fatigue impact); (3) Emotional Function (5 items addressing worry, frustration, depression, anxiety); (4) Mastery (6 items assessing confidence managing respiratory disease, feeling in control). Each item is rated on a 7-point Likert scale anchored to specific descriptors (e.g., '1'='unable to do because of breathing' to '7'='able to do without limitations'). Interview administration typically requires 20–30 minutes; self-report 10–15 minutes.

Formula
Respondent (or clinician-administered) completes 20 items across four domains via interview or self-report
2

CRQ domain scores are calculated as the mean of items within each domain, yielding continuous 1–7 domain scores (higher = better function). No total composite score is typically calculated; rather, the four domain scores are reported independently. For dyspnea, the domain score is the mean of the patient's selected activities (e.g., if patient selected 'climbing stairs' and 'walking', mean dyspnea score is average of those two items). Minimum Clinically Important Difference (MCID) is approximately 0.5 points on the 1–7 scale, though domain-specific MCID varies in literature (0.43–0.88).

Formula
Each domain scored 1–7 based on item averaging; total domain scores calculated
3

CRQ domain interpretation: Each domain score ranges 1–7; within-domain interpretation differs: Dyspnea domain scores 1–3 indicate significant dyspnea-related limitation, 4–5 moderate limitation, 6–7 minimal limitation or no limitation. Fatigue domain: scores 1–3 indicate marked fatigue, 4–5 moderate fatigue, 6–7 good energy. Emotional Function: scores 1–3 indicate marked distress (anxiety/depression), 4–5 mild distress, 6–7 good emotional well-being. Mastery: scores 1–3 indicate low confidence/loss of control, 4–5 moderate confidence, 6–7 high confidence. Clinical decision-making focuses on domain profiles: a patient with low dyspnea (6) but low mastery (2) warrants emotional support and education alongside physical rehabilitation.

Formula
Higher domain scores indicate better function; domain-specific interpretation guides clinical decisions

Common pitfalls

  • Changing dyspnea activity selection between assessments: Patients must rate the same activities at each visit for valid longitudinal comparison; if activities shift (e.g., patient stopped climbing stairs), longitudinal dyspnea comparisons become invalid
  • Misinterpreting domain independence: The four domains are related but distinct; low fatigue score does not compensate for high dyspnea limitation; review all four domains clinically
  • Over-relying on MCID without context: A 0.5-point improvement in dyspnea may be statistically meaningful but clinically marginal if baseline was already high (e.g., 2.0 → 2.5); contextualize within baseline severity and patient goals

Frequently asked questions

Can a patient use different activities for dyspnea scoring at each visit?

No, for valid longitudinal comparison, patients must rate the same dyspnea activities at each assessment. If an activity becomes irrelevant (e.g., patient stopped yard work), discuss alternative comparable activity with clinician. Changing activities confounds interpretation of change scores.

My patient improved in dyspnea and fatigue but worsened in mastery. What does this mean?

Physical improvement (less dyspnea/fatigue) may not automatically restore confidence if the patient has experienced years of disease burden. Consider addressing psychological factors: consider cognitive-behavioral therapy, peer support, or anxiety management alongside rehabilitation.

How does CRQ differ from SGRQ?

CRQ is interview-administered, multidimensional (dyspnea + fatigue + emotion + mastery), with personalized dyspnea items; highly responsive to rehabilitation. SGRQ is self-completed, 76 items, single disease-impact score; emphasis on activity limitation. CRQ preferred for rehabilitation tracking; SGRQ for general respiratory disease QoL assessment.

A patient's domain scores are 4, 4, 4, 4; is this 'acceptable' disease control?

A uniform 4 across all domains indicates moderate function with room for improvement across all areas. Clinically, '4' means moderate limitation/distress—not yet good control. Treatment goals might focus on improving dyspnea and fatigue while simultaneously addressing emotional concerns and building mastery confidence.

Related methods

Sources

  1. Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987). A measure of quality of life for clinical trials in chronic lung disease. Thorax, 42(10), 773-778.

    Open DOI reference
    Copied.
  2. Guyatt, G. H., Nogrady, S. G., Halcrow, S., Singer, J., Sullivan, M. J., & Fallen, E. L. (1989). Development and testing of a new measure of health status for clinical trials in heart failure. Journal of General Internal Medicine, 4(2), 101-107.

    Open DOI reference
    Copied.